Advertisement

Latest news

View all

Pharma Business – October 3, 2024

AstraZeneca’s Calquence granted Priority Review in the US

AstraZeneca’s supplemental New Drug Application (sNDA) for Calquence has been accepted and granted Priority Review in the US for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL).

Pharma Business – October 2, 2024

AstraZeneca’s Enhertu granted Priority Review in the US

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for Enhertu has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast cancer who have received at least one endocrine therapy in the metastatic setting based on the positive results from the DESTINY-Breast06 Phase III trial which compared Enhertu to chemotherapy.

Financing – October 2, 2024

Spago Nanomedical enters a new phase

The Board of Directors of Spago Nanomedical has decided that the company’s resources will be focused on the development of Tumorad with the company’s primary priority being the execution of the ongoing clinical study Tumorad-01 with the candidate drug 177Lu-SN201.

Financing – October 2, 2024

Senzime carries out a directed share issue of SEK 86 million

The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.

Financing – October 2, 2024

Sanofi invests in Vicore

Vicore Pharma Holding has announced an investment from Sanofi in Vicore through a commitment to subscribe for shares in the ongoing rights issue corresponding to a total of approximately USD 10 million.

Advertisement

13 EUR
/month

Read the latest issue of our magazine!

Read the latest issue of our magazine!

  • Special report: The current financial landscape. We take a closer look on different challenges, advisors and legal experts share their advice and not least, Nordic companies share their journeys.
  • Profile: Professor Anna Wedell has focused her career on inherited metabolic diseases and is the Director of the new Precision Medicine Center Karolinska. 
  • Nordic strengths: We highlight success stories from different Nordic corners, everything from Europe’s first pluripotent stem cell-based product to treat Parkinson’s to wound healing using fish skin.
Subscribe now

Advertisement

Opinion & debate

Clinical Trials

Clinical Trials – September 30, 2024

Cereno signs agreement with Fluidda and announces Phase IIa results 

Cereno Scientific has signed an agreement with medical technology company Fluidda on Respiratory Imaging solutions, with the aim to visualize signs of reverse remodeling of lead drug candidate CS1 in Pulmonary Arterial Hypertension (PAH) in a clinical setting.

Clinical Trials – September 19, 2024

Anocca presents new preclinical data

Anocca will present its novel platform approach to therapeutic TCR discovery and preclinical data for its lead TCR-T cell therapy product at the European Society of Medical Oncology (ESMO) Congress 2024.

Clinical Trials – September 18, 2024

TILT Biotherapeutics presents clinical data

The results further demonstrate the potential for TILT-123 as an intravenous therapy.

Clinical Trials – September 18, 2024

Ultimovacs discontinues patient recruitment in LUNGVAC trial

The company has agreed with the investigators conducting the LUNGVAC trial to discontinue patient recruitment.

Clinical Trials – September 17, 2024

Medivir’s fostrox + Lenvima confirm promise of improved outcomes in advanced liver cancer

Medivir has presented positive, mature data from its ongoing phase 1b / 2a study of fostroxacitabine bralpamide (fostrox) + Lenvima in advanced liver cancer at the ESMO Congress in Barcelona, Spain.

Clinical Trials – September 14, 2024

Evaxion reports 69% Overall Response Rate in its phase 2 trial

Evaxion Biotech has announced new clinical phase 2 data for its lead compound EVX-01.

Follow NLS news
Follow us on XFollow us on Linkedin

NLS Insight

Science Award – March 10, 2023

How cells manage oxygen

The 2019 Nobel Prize in Physiology or Medicine was awarded to William G. Kaelin Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza for revealing the mechanism of one of life’s most essential adaptive processes.

Science – July 8, 2024

The genetics of obesity

Unfortunately genes do matter when it comes to obesity, but knowledge about these genes and how they work are key to improving treatment and prevention. “Over the past two decades, genetic association studies have identified hundreds of genetic variations that affect body weight. Individuals who inherit many of these variations are more susceptible to gaining […]

Profiles in Business – July 28, 2021

Mathias Uhlén – Driven by curiosity and courage

Being a scientist or an entrepreneur is hard enough. Doing both at the same time sounds like an Olympic sport. Swedish scientist and “serial entrepreneur” Dr. Mathias Uhlén, PhD., professor at KTH Royal Institute of Technology, though, makes it look easy. Not only has he founded more than 20 companies in recent years, but his […]

Follow NLS news
Follow us on XFollow us on Linkedin

Explore topics

Upcoming events

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.